Close
UCL Queen Square MND Centre Hybrid Seminar: Dr Frances Theunissen
10 June 2024, 2:00 pm–3:00 pm
The Present and Future of Precision Medicine: Antisense oligonucleotides to target ALS disease mechanisms
This event is free.
Event Information
Open to
- All
Availability
- Yes
Cost
- Free
Organiser
-
Debbie Hadley – University College London02031082731
Location
-
Third Floor Meeting RoomQueen Square HouseUCL Queen Square Institute of NeurologyLondonWC1N 3BGUnited Kingdom
Dr Frances Theunissen
will present
The Present and Future of Precision Medicine: Antisense oligonucleotides to target ALS disease mechanisms.
In-Person Venue:
Third Floor Meeting Room (310), Queen Square House
MS Teams Link:
Contact - d.hadley@ucl.ac.uk
About the Speaker
Frances Theunissen
Postdoctoral Research Scientist
Dr Frances Theunissen is the FightMND Early Career Research Fellow at The University of Notre Dame Australia, Honorary Research Associate at the Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, and a member of the MND Genetics and Therapeutics Laboratory at the Perron Institute for Neurological and Translational Science. She completed her PhD in 2023, at Murdoch University. Her research is focused on the co-development of companion diagnostic genetic markers in combination with precision molecular therapies for the treatment of motor neurone disease. Frances is the co-lead of genetic marker development for biotech company Black Swan Pharmaceuticals, driving the genetic enrichment strategies for their antisense therapy portfolio
More about Frances TheunissenOther events in this series